Clinical Diagnosis And Management Of Alzheimer S Disease

Owing to the success of the first edition and the rapid development of new drugs for treating Alzheimer's disease, Serge Gauthier has approached not only his original contributors but a number of leading clinicians and researchers to give their views based on clinical experience and scientific evidence for the treatment of this disease.

A study of the clinical diagnosis and management of Alzheimer's disease. This new edition contains not only the original contributions but a number of clinicians and researchers also give their views based on clinical experience and scientific evidence for the treatment of this disease.

The third edition of this successful textbook has been completely updated throughout and includes new chapters on electrophysiological tests, biological markers, global staging measures, and management of neuropsychiatric symptoms. There has been steady progress in our understanding of the natural history, prognostic factors and treatments for Alzheimer’s disease since the previous edition of this textbook was published in 1999. The chapters deal with the full spectrum of populations at risk, persons in prodromal stages, and patients from mild to severe and even terminal stages. The contributors are opinion leaders from North America and Europe, which gives the book an internationally balanced outlook. This new edition will be essential reading for a wide range of clinical neuroscientists who manage patients with this challenging disease.

Alzheimer's disease is not only a dementia, to the lay public it is the dementia. Clinical Diagnosis and Management of Alzheimer's Disease, under the editorial guidance of Serge Gauthier, is written by an international and multidisciplinary team which represents the reality of Alzheimer's disease. Contributors from different institutions, and different countries, have collaborated on individual chapters so that the reader is offered an international and personal perspective. Alzheimer's disease has no boundaries: it is a condition which affects all people of all countries; a condition that requires the help of both doctor and family, the community and the individual. The information provided here reflects work in progress on aetiology, clinical and laboratory assessment, natural evolution, medical and non-medical management.

The third edition of this successful textbook has been completely updated throughout and includes new chapters on electrophysiological tests, biological markers, global staging measures, and management of neuropsychiatric symptoms. There has been steady progress in our understanding of the natural history, prognostic factors and treatments for Alzheimer’s disease since the previous edition of this textbook was published in 1999. The chapters deal with the full spectrum of populations at risk, persons in prodromal stages, and patients from mild to severe and even terminal stages. The contributors are opinion leaders from North America and Europe, which gives the book an internationally balanced outlook. This new edition will be essential reading for a wide range of clinical neuroscientists who manage patients with this challenging disease.

Biomarkers in Alzheimer’s Disease provides a comprehensive overview of all modalities of Alzheimer’s disease biomarkers, including neuroimaging, cerebrospinal fluid, genomic, and peripheral systems. Each chapter integrates molecular/cellular abnormality due to Alzheimer’s disease and technological advancement of biomarkers techniques. The book is ideal for clinical neuroscience and molecular/cellular neuroscience researchers, psychiatrists, and allied healthcare practitioners involved in the diagnosis and management of patients with cognitive impairment and Alzheimer’s disease, and for differential diagnosis of Alzheimer’s disease with other non-Alzheimer’s dementia. Presents a comprehensive overview detailing all modalities of Alzheimer’s disease biomarkers Written for neuroscience researchers and clinicians studying or treating patients with Alzheimer’s Disease Integrates, in each chapter, the molecular/cellular abnormality due to Alzheimer’s disease and the technological advancement of biomarkers techniques

This book provides a practically focused resource on the methodologies available for diagnosing and treating Alzheimer’s disease. The number of individuals affected by the disease continues to grow and as such there is an ever-increasing need for clear easy-to-digest guidance on how to appropriately diagnose and treat these patients. Within this work, chapters provide concise informative details of what this form of dementia is, how it can be diagnosed, managed and prevented making it ideal for those with limited experience in dealing with these patients. Information is provided on how to use a variety of the latest relevant techniques including mental state examinations, functional assessments, special investigations and the available drug treatments. Alzheimer’s Disease: Diagnosis & Treatment Guide is a concise clinical guide detailing how to diagnose and treat these patients. It’s easy-to-follow ideal for use by front-line physicians and trainees, who have no previous experience of diagnosing and treating this disease. The assessment component of the book is based on the WHO Mental Health Gap Action Plan (mhGAP) Dementia Intervention Guide for non-specialized settings.

Dementia: From Diagnosis to Management - A Functional Approach is a comprehensive description of a functional and behavioral approach to assessing and treating persons with dementia. While very practical, the information is embedded in a scientific context of the causes, neuropsychological manifestations, and complications of dementia. The management of the impairments of dementia is centered on its functional consequences and impact on daily living. The chapters describe behavioral interventions and environmental strategies that aim to improve daily activities and quality of life from a proactive communication and memory basis. Specific suggestions are provided to enhance family involvement and staff relationships, interdisciplinary cooperation, reimbursement, and documentation across various home and institutional settings. The book is written in a straightforward style and is evenhanded in its critical analyses of the evidence available to inform practice. The extensive clinical backgrounds of the authors allow them to use ‘real world’ case studies to illustrate common challenges of persons with dementia and potential solutions for caregivers. Further resources and clinical materials are included in comprehensive appendices. The volume provides essential reading for clinicians and administrators who seek to improve the lives of people with dementia and those who care for them. It is also an invaluable reference for beginning students in adult language disorders and gerontology.